Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Hershman randomized women receiving adjuvant taxane chemotherapy for early breast cancer evenly to either oral ALC 1,000 mg three times daily or matching placebo, for 24 weeks
stable under GIrelevant pH and typical processing heat (per PKpaper stability data)
IGF-1 LR3 Formulation : Lyophilized from a 0.2 m filtered solution of 300mM HAc-NaAc, pH 6.5
If the shortage ends, one type of compounding pharmacy (called 503a) would be required to stop production immediately, while 503b pharmacies, which typically produce on a larger scale, would have 60 days
Presented for research literature review only Kuhn KS et al
Moran LV, Ongur D, Hsu J, et al
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
